Mayinglong Pharmaceutical Group Co., Ltd.

Mayinglong Pharmaceutical Group Co., Ltd.verified

600993.SS

Price:

$29.73

Market Cap:

$12.82B

Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, functional food, and Chinese medicine drink tablet products, as well as medical devices. The company also sells its products online. It also operates hospitals. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is based in Wuhan, China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2004-05-17

Stock Exchange

SHH

Ticker

600993.SS

The PE Ratio as of December 2025 (TTM) for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) is 22.35

According to Mayinglong Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 22.35. This represents a change of -3.71% compared to the average of 23.21 of the last 4 quarters.

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) Historical PE Ratio (quarterly & annually)

How has 600993.SS PE Ratio performed in the past?

The mean historical PE Ratio of Mayinglong Pharmaceutical Group Co., Ltd. over the last ten years is 26.97. The current 22.35 PE Ratio has changed 8.19% with respect to the historical average. Over the past ten years (40 quarters), 600993.SS's PE Ratio was at its highest in in the December 2023 quarter at 104.78. The PE Ratio was at its lowest in in the March 2024 quarter at 12.14.

Quarterly (TTM)
Annual

Average

26.97

Median

25.08

Minimum

20.36

Maximum

42.31

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mayinglong Pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 28.80%

Maximum Annual PE Ratio = 42.31

Minimum Annual Increase = -33.33%

Minimum Annual PE Ratio = 20.36

Quarterly (TTM)
Annual
YearPE RatioChange
202421.31-9.22%
202323.4815.33%
202220.36-23.71%
202126.6828.80%
202020.72-1.09%
201920.94-33.33%
201831.4111.76%
201728.11-18.33%
201634.42-18.65%
201542.3127.55%

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) Average PE Ratio

How has 600993.SS PE Ratio performed in the past?

The current PE Ratio of Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.71

5-year avg

22.51

10-year avg

26.97

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) PE Ratio vs. Peers

How is 600993.SS’s PE Ratio compared to its peers?

Mayinglong Pharmaceutical Group Co., Ltd.’s PE Ratio is less than Xiamen Kingdomway Group Company (23.91), greater than Guobang Pharma Ltd. (14.54), greater than Henan Lingrui Pharmaceutical Co., Ltd. (15.00), greater than Zhejiang Hisun Pharmaceutical Co., Ltd. (21.61), less than Changzhou Qianhong Biopharma CO.,LTD (22.89), greater than Jiang Zhong Pharmaceutical Co.,Ltd (18.53), greater than KPC Pharmaceuticals, Inc. (17.84), greater than Shanghai Shyndec Pharmaceutical Co., Ltd. (14.82), greater than Zhejiang Medicine Co., Ltd. (10.64), greater than Chongqing Taiji Industry(Group) Co.,Ltd (-28.31),

Build a custom stock screener for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mayinglong Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mayinglong Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Mayinglong Pharmaceutical Group Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)?

What is the highest PE Ratio for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)?

What is the 3-year average PE Ratio for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)?

What is the 5-year average PE Ratio for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)?

How does the current PE Ratio for Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) compare to its historical average?